IQVIA Holdings EPS - Earnings per Share 2011-2025 | IQV

IQVIA Holdings earnings per share (EPS) for the twelve months ending March 31, 2025 was $7.33, a 0.14% increase year-over-year.

  • IQVIA Holdings EPS for the quarter ending March 31, 2025 was $1.40, a 10.26% decline year-over-year.
  • IQVIA Holdings 2024 annual EPS was $7.49, a 2.74% increase from 2023.
  • IQVIA Holdings 2023 annual EPS was $7.29, a 27.45% increase from 2022.
  • IQVIA Holdings 2022 annual EPS was $5.72, a 15.56% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

IQVIA Holdings EPS - Earnings per Share 2011-2025 | IQV

  • IQVIA Holdings EPS for the quarter ending March 31, 2025 was $1.40, a 10.26% decline year-over-year.
  • IQVIA Holdings 2024 annual EPS was $7.49, a 2.74% increase from 2023.
  • IQVIA Holdings 2023 annual EPS was $7.29, a 27.45% increase from 2022.
  • IQVIA Holdings 2022 annual EPS was $5.72, a 15.56% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$171.9B
Thermo Fisher Scientific (TMO)$161.4B
Alcon (ALC)$45.6B
Edwards Lifesciences (EW)$42B
IDEXX Laboratories (IDXX)$33.3B
DexCom (DXCM)$26.9B
STERIS (STE)$21.8B
Mettler-Toledo (MTD)$20.9B
Waters (WAT)$19.1B
SONOVA HOLDING (SONVY)$17.3B
Fresenius Medical Care AG KGaA (FMS)$13.9B
Hologic (HOLX)$12.9B
Sysmex ADR (SSMXY)$11.8B
Penumbra (PEN)$10.7B
Globus Medical (GMED)$9.8B
Masimo (MASI)$8.2B
Teleflex (TFX)$6B
Glaukos (GKOS)$5.2B
Integer Holdings (ITGR)$4.1B
TransMedics (TMDX)$3B
PROCEPT BioRobotics (PRCT)$2.9B
Veracyte (VCYT)$2.4B
Nihon Kohden (NHNKY)$2.1B
LivaNova (LIVN)$1.9B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.5B
Integra LifeSciences Holdings (IART)$1.2B
Pulse Biosciences (PLSE)$1.2B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B